Progestogen-only Injectables

FSRH Clinical Guideline: Progestogen-only Injectable (December 2014, Amended October 2020)

24 October 2020

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate (DMPA), Depo-Provera) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

This document is up-to-date

FSRH New Product Review: Sayana Press® (June 2013)

01 June 2013

Injectable progestogen-only contraception is a popular and effective method of contraception and until now, in the UK has largely been administered as Depo-Provera®, an intramuscular (IM) injection of 150mg medroxyprogesterone acetate (DMPA).

This document is up-to-date